NCT04568239View on ClinicalTrials.gov

Impact of M184V on the Virological Efficacy to 3TC/DTG (LAMRES)

CompletedOBSERVATIONAL

Enrollment

712

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

June 1, 2022

Study Completion Date

August 1, 2022

Conditions

HIV-1-infection

Trial Locations (1)

Unknown

ARVD, Paris

All Listed Sponsors

lead

Association de Recherche en Virologie et Dermatologie

OTHER

NCT04568239 - Impact of M184V on the Virological Efficacy to 3TC/DTG (LAMRES) | Biotech Hunter | Biotech Hunter